Ceapro Inc. Reports 2023 Second Quarter and Six-Month Financial Results and Provides Corporate Update August 29, 2023
Ceapro Extends Exclusive International Supply and Distribution Agreement with Leading Global Provider of Active Ingredients, Symrise August 25, 2023
Ceapro Inc. Reports Financial Results for First Quarter 2023 and Provides Corporate Update May 25, 2023
Ceapro Inc. Presents Encouraging Results from Research Collaboration Study with McMaster University Evaluating PGX-Processed Yeast Beta Glucan for Interstitial Lung Diseases May 23, 2023
Ceapro Announces Positive Findings Demonstrating Oat Derived Beta Glucan and Avenanthramides Promote Wound Healing and Tissue Regeneration May 3, 2023
